Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36


Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations.

Brigida AL, Schultz S, Cascone M, Antonucci N, Siniscalco D.

Int J Mol Sci. 2017 Jul 3;18(7). pii: E1425. doi: 10.3390/ijms18071425. Review.


Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis?

Giacoppo S, Mazzon E.

Neural Regen Res. 2016 Dec;11(12):1896-1899. doi: 10.4103/1673-5374.197125. Review.


Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease.

Kendall DA, Yudowski GA.

Front Cell Neurosci. 2017 Jan 4;10:294. doi: 10.3389/fncel.2016.00294. eCollection 2016. Review.


Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy.

Babayeva M, Assefa H, Basu P, Chumki S, Loewy Z.

Parkinsons Dis. 2016;2016:1279042. doi: 10.1155/2016/1279042. Epub 2016 Dec 5. Review.


Effects of Cannabis sativa extract on haloperidol-induced catalepsy and oxidative stress in the mice.

Abdel-Salam OM, El-Sayed El-Shamarka M, Salem NA, El-Din M Gaafar A.

EXCLI J. 2012 Feb 24;11:45-58. eCollection 2012.


Chronic Δ(9)-Tetrahydrocannabinol Administration Reduces IgE(+)B Cells but Unlikely Enhances Pathogenic SIVmac251 Infection in Male Rhesus Macaques of Chinese Origin.

Wei Q, Liu L, Cong Z, Wu X, Wang H, Qin C, Molina P, Chen Z.

J Neuroimmune Pharmacol. 2016 Sep;11(3):584-591. doi: 10.1007/s11481-016-9674-9. Epub 2016 Apr 25.


Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis.

Hammell DC, Zhang LP, Ma F, Abshire SM, McIlwrath SL, Stinchcomb AL, Westlund KN.

Eur J Pain. 2016 Jul;20(6):936-48. doi: 10.1002/ejp.818. Epub 2015 Oct 30.


Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist.

Presley C, Abidi A, Suryawanshi S, Mustafa S, Meibohm B, Moore BM.

Pharmacol Res Perspect. 2015 Aug;3(4):e00159. doi: 10.1002/prp2.159. Epub 2015 Jul 6.


New horizons for newborn brain protection: enhancing endogenous neuroprotection.

Hassell KJ, Ezzati M, Alonso-Alconada D, Hausenloy DJ, Robertson NJ.

Arch Dis Child Fetal Neonatal Ed. 2015 Nov;100(6):F541-52. doi: 10.1136/archdischild-2014-306284. Epub 2015 Jun 10. Review.


Sigma receptors [σRs]: biology in normal and diseased states.

Rousseaux CG, Greene SF.

J Recept Signal Transduct Res. 2015 Jun 9:1-62. [Epub ahead of print]


Novel targets for Spinal Cord Injury related neuropathic pain.

Ahmed MM, King KC, Pearce SM, Ramsey MA, Miranpuri GS, Resnick DK.

Ann Neurosci. 2011 Oct;18(4):162-7. doi: 10.5214/ans.0972.7531.1118413. Review.


Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system.

Lee J, Jo DG, Park D, Chung HY, Mattson MP.

Pharmacol Rev. 2014 Jul;66(3):815-68. doi: 10.1124/pr.113.007757. Review.


Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study.

Fichna J, Wood JT, Papanastasiou M, Vadivel SK, Oprocha P, Sałaga M, Sobczak M, Mokrowiecka A, Cygankiewicz AI, Zakrzewski PK, Małecka-Panas E, Krajewska WM, Kościelniak P, Makriyannis A, Storr MA.

PLoS One. 2013 Dec 27;8(12):e85073. doi: 10.1371/journal.pone.0085073. eCollection 2013.


Intranodose ganglion injections of dronabinol attenuate serotonin-induced apnea in Sprague-Dawley rat.

Calik MW, Radulovacki M, Carley DW.

Respir Physiol Neurobiol. 2014 Jan 1;190:20-4. doi: 10.1016/j.resp.2013.10.001. Epub 2013 Oct 11.


Cannabinoid hyperemesis syndrome with extreme hydrophilia.

Enuh HA, Chin J, Nfonoyim J.

Int J Gen Med. 2013 Aug 19;6:685-7. doi: 10.2147/IJGM.S49701. eCollection 2013.


Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction.

Panlilio LV, Justinova Z, Goldberg SR.

Pharmacol Ther. 2013 Apr;138(1):84-102. doi: 10.1016/j.pharmthera.2013.01.003. Epub 2013 Jan 16. Review.


Marijuana, Spice 'herbal high', and early neural development: implications for rescheduling and legalization.

Psychoyos D, Vinod KY.

Drug Test Anal. 2013 Jan;5(1):27-45. doi: 10.1002/dta.1390. Epub 2012 Aug 13. Review.


Cannabinoid hyperemesis: a case series of 98 patients.

Simonetto DA, Oxentenko AS, Herman ML, Szostek JH.

Mayo Clin Proc. 2012 Feb;87(2):114-9. doi: 10.1016/j.mayocp.2011.10.005.


Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients: Results of a Multicenter Survey.

Weber J, Schley M, Casutt M, Gerber H, Schuepfer G, Rukwied R, Schleinzer W, Ueberall M, Konrad C.

Anesthesiol Res Pract. 2009;2009. pii: 827290. doi: 10.1155/2009/827290. Epub 2009 Oct 25.


WIN55,212-2 inhibits production of CX3CL1 by human astrocytes: involvement of p38 MAP kinase.

Sheng WS, Hu S, Ni HT, Rock RB, Peterson PK.

J Neuroimmune Pharmacol. 2009 Jun;4(2):244-8. doi: 10.1007/s11481-009-9147-5. Epub 2009 Feb 12.

Supplemental Content

Support Center